39 completed, 6 unknown, 2 recruiting, 2 terminated. 51 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 51 | Completed 39, Unknown 6, Recruiting 2, Terminated 2, Not yet recruiting 1, Withdrawn 1 |
Follow Dyslipidemia: new trials by email Literature Review of Dyslipidemia trials Research Report on Dyslipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome bempedoic acid, Ezetimibe, High-Intensity Statin Therapy - Acute Coronary Syndromes, Dyslipidemia | Phase 4 | Recruiting | Taipei Medical University Hospital | 400 | 2026-08-26 | 2026-09-17 |
| Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study Yangxin Dawayimixike Honey Paste, Yangxin Dawayimixike Honey Paste placebo - Dyslipidemia, Carotid Atherosclerotic Plaques | Phase 4 | Not yet recruiting | Xinjiang Uygur Pharmaceutical Co., Ltd. | 422 | 2026-01-01 | 2026-01-02 |
| Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia Rosuvastatin Immediate-Release Tablet (IRT) 10mg, Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg - Dyslipidemia | Phase 4 | Unknown | Yonsei University | 112 | 2023-11-06 | 2023-12-01 |
| Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia Choline fenofibrate, Policosanol - Dyslipidemia, Atherosclerosis | Phase 4 | Recruiting | Seoul National University Bundang Hospital | 56 | 2023-06-01 | 2026-05-05 |
| Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension Duowell®, Telmisartan - Hypertension, Dyslipidemia | Phase 4 | Completed | Yuhan Corporation | 80 | 2017-09-11 | 2021-04-06 |
| Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) Alirocumab, Statins, Ezetimibe - Dyslipidemia | Phase 4 | Completed | Sanofi | 413 | 2016-03-15 | 2018-05-01 |
| Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir pitavastatin, placebo - HIV, Dyslipidemia | Phase 4 | Completed | Ramathibodi Hospital | 24 | 2014-05-01 | 2016-10-10 |
| The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients Ezetimibe - Dyslipidemia, Transplants | Phase 4 | Completed | University Medical Centre Ljubljana | 80 | 2014-04-01 | 2016-05-17 |
| Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study) Jinlida granules, placebo granules - Type 2 Diabetes, Dyslipidemia | Phase 4 | Unknown | Shanghai Jiao Tong University School of Medicine | 360 | 2014-02-01 | 2014-01-14 |
| A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406) Ezetimibe/simvastatin, Other Statin - Dyslipidemia | Phase 4 | Withdrawn | Organon and Co | 2013-03-01 | 2022-02-18 | |
| Effects of Metformin on Hepatic FFA Metabolism Metformin, Placebo - Type 2 Diabetes, Dyslipidemia | Phase 4 | Completed | Lars Christian Gormsen | 36 | 2013-01-01 | 2019-10-15 |
| Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin Rosuvastatin 5 mg, Rosuvastatin 10 mg - Dyslipidemia | Phase 4 | Unknown | D16 Pharma & Biotec Ltd. | 2000 | 2012-07-01 | 2012-09-25 |
| Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients Statin withdrawal - Type 2 Diabetes Mellitus, Atherosclerosis | Phase 4 | Completed | University of Padova | 34 | 2012-05-01 | 2013-08-13 |
| Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors Truvada® (300 mg tenofovir disoproxil fumarato/200 mg emtricitabine), Placebo - HIV, Dyslipidemia | Phase 4 | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 48 | 2012-01-01 | 2014-06-19 |
| Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease intensive control, standard control - Type 2 Diabetes, Coronary Artery Disease | Phase 4 | Completed | Takeshi Morimoto | 798 | 2011-08-01 | 2024-06-14 |
| A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects Pitavastatin, Pravastatin - Dyslipidemia | Phase 4 | Completed | Kowa Research Institute, Inc. | 252 | 2010-12-01 | 2014-04-29 |
| Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy Placebo, Colesevelam - Dyslipidemia, Hyperlipidemia | Phase 4 | Completed | Radiant Research | 140 | 2010-11-01 | 2012-01-06 |
| The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients Tredaptive (1 g extended release niacin+ 20 mg laropiprant), Placebo, Tredaptive - Coronary Artery Disease, Dyslipidemia | Phase 4 | Terminated | Sheba Medical Center | 8 | 2010-07-01 | 2016-10-19 |
| A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia Xuezhikang capsule - Dyslipidemia | Phase 4 | Completed | China Academy of Chinese Medical Sciences | 2400 | 2010-03-01 | 2014-02-07 |
| Study of Trilipix Effects on Lipids and Arteries Trilipix, placebo - Dyslipidemia | Phase 4 | Terminated | University of Utah | 24 | 2009-11-01 | 2016-09-01 |
Showing 20 of 51. Sign in to see all of them.
Dyslipidemias (51) · Diabetes Mellitus, Type 2 (9) · Hypertension (9) · Atherosclerosis (6) · Coronary Artery Disease (5) · Diabetes Mellitus (4) · Acute Coronary Syndrome (3) · HIV Infections (3) · Hypercholesterolemia (3) · Hyperlipidemias (3) · Stroke (3) · Acquired Immunodeficiency Syndrome (2) · Coronary Disease (2) · Hypertriglyceridemia (2) · Inflammation (2)
Lipid Metabolism Disorders (51) · Metabolic Diseases (51) · Nutritional and Metabolic Diseases (51) · Cardiovascular Diseases (20) · Vascular Diseases (20) · Glucose Metabolism Disorders (16) · Endocrine System Diseases (14) · Arterial Occlusive Diseases (11) · Arteriosclerosis (11) · Heart Diseases (10) · Myocardial Ischemia (10) · Diabetes Mellitus (9) · Coronary Disease (5) · Pathological Conditions, Signs and Symptoms (5) · Brain Diseases (4)
Atorvastatin (9) · Ezetimibe (5) · Fenofibrate (5) · Niacin (5) · Rosuvastatin Calcium (5) · Fluvastatin (3) · Simvastatin (3) · Colesevelam Hydrochloride (2) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (2) · MK-0524 (2) · Metformin (2) · amlodipine, atorvastatin drug combination (2) · pitavastatin (2) · 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (1) · Amlodipine (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (6) · Novartis (4) · Sanofi (2) · Brown, Todd, M.D., Ph.D. (1) · Central South University (1) · China Academy of Chinese Medical Sciences (1) · Chong Kun Dang Pharmaceutical (1) · D16 Pharma & Biotec Ltd. (1) · Enzymotec (1) · Foundation for Cardiovascular Research, Zurich (1) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1) · Genovate Biotechnology Co., Ltd., (1) · Hartford Hospital (1) · In His Image (1) · Institut Investigacio Sanitaria Pere Virgili (1)
United States (13) · Switzerland (5) · South Korea (4) · Spain (4) · Germany (3) · Israel (3) · Italy (3) · Canada (2) · China (2) · Greece (2) · Hungary (2) · Japan (2) · Russia (2) · Sweden (2) · Taiwan (2)
Adrian S Dobs, MD (1) · Asita Wongprikorn (1) · Charles M White, PharmD (1) · Chen Chih-Ken, PhD (1) · Chii-Min Hwu, MD (1) · Chun-Yao Huang, MD, PhD (1) · David Leaf, MD (1) · Dror Harats, M.D. (1) · Edward Rylander, MD (1) · Eliot Brinton, MD (1) · Gian Paolo Fadini, M.D. (1)
PMID 17626713, PMID 18312764, PMID 18653575, PMID 19217176, PMID 20617456, PMID 20732372, PMID 21610204, PMID 23046818, PMID 23274145, PMID 23600368, PMID 23683266, PMID 24379928, PMID 24618208, PMID 25456755, PMID 25870325, PMID 27304841, PMID 28121706, PMID 28252528, PMID 28416195, PMID 28545518, PMID 29436756, PMID 30976851, PMID 31706300, PMID 32035487, PMID 33078867, PMID 35727095, PMID 37776319
2015 (1), K23AT002862 (1)